In a B-cell lymphoma cell line derived from a BALB/c mice model, O’Hara et al. showed that clarithromycin inhibited cell viability and induced apoptosis though down-regulating BCL-2 expression76. This evidence concerns the gene BCL2 and B-cell non-Hodgkin lymphoma.